Literature DB >> 7199148

Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension.

A Drukker, J Urbach, J Glaser.   

Abstract

Cardiac function was evaluated by echocardiography (echo) in ten paediatric patients, 2.5 to 15 years of age, maintained on chronic dialysis. All had moderate to severe hypertension despite intensive antihypertensive medication. Four of ten patients showed, on echo, asymmetric septal hypertrophy (ASH) typical of hypertrophic cardiomyopathy (HCM). Two also had signs suggestive of outflow obstruction. Primary cardiomyopathy was excluded by a family survey of first-degree relatives. The incidence of HCM in our series is impressive (40%). The pathogenesis of this cardiac lesion in uraemia is unknown; long-standing severe hypertension may play a role. Early recognition of this form of cardiomyopathy has important clinical considerations. Echo should become a routine examination in the diagnosis, follow-up, and treatment of children with end-stage renal disease.

Entities:  

Mesh:

Year:  1981        PMID: 7199148

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  6 in total

1.  Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Maria Albina Galli; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-11-15       Impact factor: 3.714

2.  Diagnosis of cardiac disease in pediatric end-stage renal disease.

Authors:  Blanche M Chavers; Craig A Solid; Alan Sinaiko; Frank X Daniels; Shu-Cheng Chen; Allan J Collins; Diane L Frankenfield; Charles A Herzog
Journal:  Nephrol Dial Transplant       Date:  2010-09-22       Impact factor: 5.992

3.  Cardiac abnormalities in end stage renal failure and anaemia.

Authors:  K P Morris; J R Skinner; C Wren; S Hunter; M G Coulthard
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 4.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 5.  Cardiovascular complications of pediatric chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

6.  Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study.

Authors:  Heesun Lee; Kyungdo Han; Jun-Bean Park; In-Chang Hwang; Yeonyee E Yoon; Hyo Eun Park; Su-Yeon Choi; Yong-Jin Kim; Goo-Yeong Cho; Hyung-Kwan Kim; Steve R Ommen
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.